Literature DB >> 30799180

Intraocular lens power calculation in eyes with keratoconus.

Giacomo Savini1, Rosa Abbate2, Kenneth J Hoffer3, Alessandro Mularoni4, Aurelio Imburgia4, Luca Avoni5, Domenico D'Eliseo5, Domenico Schiano-Lomoriello6.   

Abstract

PURPOSE: To assess the refractive accuracy of different formulas for intraocular lens (IOL) power calculation in eyes with keratoconus.
SETTING: IRCCS Fondazione Bietti, Rome, Italy.
DESIGN: Multicenter retrospective interventional study.
METHODS: A consecutive series of eyes with keratoconus that had cataract surgery were evaluated. Keratometry, anterior chamber depth, and axial length were measured preoperatively with optical biometry; IOL power was calculated with the Barrett Universal II, Haigis, Hoffer Q, Holladay 1, and SRK/T formulas. Subjective refraction was assessed at 1 month. The mean prediction error (PE), median absolute error (MedAE) and percentage of eyes with a PE within ±0.50 diopters (D), ±0.75 D, and ±1.00 D were calculated.
RESULTS: The final spherical equivalent was -0.52 D ±1.61 (SD). In the whole sample (41 eyes), the mean PE was positive (hyperopic surprise) with all formulas; the lowest PE (0.91 D) and MedAE (0.62 D) were obtained with the SRK/T formula. In stage I eyes (n = 21), the MedAE ranged between 0.43 and 0.91 D; the SRK/T formula achieved the lowest MedAE and the highest rate of eyes with a PE within ±0.50 (61.9%). In stage II eyes (n = 13), the MedAE ranged between 0.75 D and 1.50 D; the SRK/T formula achieved the lowest MedAE and the highest rate of eyes with a PE within ±0.50 (30.8%). In stage III eyes (n = 7), the MedAE was higher than 2.50 D with all formulas.
CONCLUSIONS: In keratoconus eyes, all formulas led to a hyperopic refractive outcome. The SRK/T was the most accurate formula. The results were worse in advanced stages of the disease.
Copyright © 2018 ASCRS and ESCRS. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 30799180     DOI: 10.1016/j.jcrs.2018.11.029

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  7 in total

1.  Intraocular lens power calculation in patients with irregular astigmatism.

Authors:  Asaf Achiron; Omar Elhaddad; Duncan Leadbetter; Eliya Levinger; Oleksiy Voytsekhivskyy; Katy Smith; Venkata Avadhanam; Kieren Darcy; Derek Tole
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-07-01       Impact factor: 3.117

Review 2.  Refractive Outcomes of Non-Toric and Toric Intraocular Lenses in Mild, Moderate and Advanced Keratoconus: A Systematic Review and Meta-Analysis.

Authors:  Tal Yahalomi; Asaf Achiron; Idan Hecht; Roee Arnon; Eliya Levinger; Joseph Pikkel; Raimo Tuuminen
Journal:  J Clin Med       Date:  2022-04-27       Impact factor: 4.964

3.  Agreement of total corneal power between 2 swept-source optical coherence tomography and Scheimpflug tomography in normal and keratoconic patients.

Authors:  Rosepon Asawaworarit; Vannarut Satitpitakul; Parichart Taweekitikul; Krit Pongpirul
Journal:  PLoS One       Date:  2022-05-24       Impact factor: 3.752

4.  Different lens power calculation formulas for the prediction of refractive outcome after phacoemulsification with silicone oil removal.

Authors:  Yanan Hou; Lei Liu; Gang Wang; Junwei Xie; Yi Wang
Journal:  BMC Ophthalmol       Date:  2022-02-13       Impact factor: 2.209

Review 5.  Update on Intraocular Lens Formulas and Calculations.

Authors:  Tina Xia; Christine E Martinez; Linda M Tsai
Journal:  Asia Pac J Ophthalmol (Phila)       Date:  2020 May-Jun

6.  An innovative approach for determining the customized refractive index of ectatic corneas in cataractous patients.

Authors:  Shiva Pirhadi; Keivan Maghooli; Khosrow Jadidi
Journal:  Sci Rep       Date:  2020-10-07       Impact factor: 4.379

7.  Correlating Kane formula with existing intraocular lens formulae for corneal curvatures and axial lengths.

Authors:  P Priji; Sajeev Cherian Jacob; Lavanya Kalikivayi; Venkataramana Kalikivayi
Journal:  Oman J Ophthalmol       Date:  2021-06-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.